期刊文献+

抑郁症相关受体、细胞因子及信号通路的研究进展 被引量:10

Progress of Receptors, Cytokine and Signal Pathways about Depression
下载PDF
导出
摘要 抑郁症是指某种不愉快的心境和一定身体器官的功能紊乱,是一种精神病理状态,迄今为止对抑郁症的治疗及病因研究已有一定的进展,目前的研究认为五羟色胺、多巴胺等单胺类神经递质与抑郁症的发生和治疗有密切的关系,同时,有研究也发现谷氨酸、糖皮质激素等非单胺类系统也与抑郁症密切相关。大量研究显示,在抑郁症患者脑中细胞外调节蛋白激酶的活性降低,而且抑制该酶的活性在动物模型上可表现出类似抑郁的行为。脑源性神经营养因子在抑郁症患者及抑郁症动物模型血液中的水平与正常对照相比均有明显的下调,而且脑源性神经营养因子在抑郁动物模型上有抗抑郁的作用。该文主要对近期与抑郁症相关的受体、细胞因子及细胞通路研究进行综述。 Depression is a mental disease with negative mood and dysfunction of organs. The study of the pathogenesis of depression has made great progress. The current research demonstrates that the disorder of serotonin system and dopamine system are related to depression; a close relationship between depression and the disorder of monoaminergic systems has been repeatedly reported. Researchers also find that the glutamatergic system and glucocorticoid system affect the development and progress of depression. The level of brain-derived neurotrophic factor is significantly decreased in the blood of depressed patients and animal models, and brain-derived neruotrophic factor has a therapeutic effect in animal models of depression. Extracellular signal-regulated kinase is also decreased in depressed patients. This review summarizes the recent understanding about the receptors, cytokine and signal pathway that are thought to be involved in the pathophysiology of depression.
作者 董栋 王蕊
出处 《神经药理学报》 2012年第5期24-30,共7页 Acta Neuropharmacologica
基金 国家自然科学基金项目(No.81072627) 教育部111项目(No.B07023) 浦江人才计划项目(No.11PJ1402300) 上海市科学技术委员会上海市新药设计重点实验室项目(No.11DZ2260600) 上海市科学技术委员会重点项目(No.12431900901)
关键词 抑郁症 五羟色胺受体 谷氨酸受体 细胞外调节蛋白激酶 神经营养因子 depression 5-hydroxy tryptamine receptor glutamate receptor extracellular regulated protein kinase neurotrophic factor
  • 相关文献

参考文献53

  • 1Hoyer D,Martin G. 5-HT receptor classification and nomenclature:towards a harmonization with the human genome[J]. Neuropharmacology, 1997,36 (4-5): 419-428.
  • 2Lesch K P, Disselkamp-Tietze J, Schmidtke A. 5-HT1A receptor function in depression:effect of chronic amitriptyline treatment[J]. J Neural Transm Gen Sect, 1990,80 (2): 157-161.
  • 3Paul R Albert. Transcriptional regulation of the 5-HT1A receptor:implications for mental illness[J]. Philos Trans R Soc Biol Sci,2012,367 (1601):2402-2415.
  • 4Li Yan,Kasper F Raaby,Connie Sanchez,et al. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats[J]. Behav Brain Res, 2013,256 : 520-528.
  • 5Nugent A C,Carlson P J,Bain E E,et al. Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression[J]. J Psychopharmacol, 2013,27 ( 10 ): 894-902.
  • 6James W Murrough, Shannan Henry, Hu J, et al. Reduced ventral striatal/ventral pallidal serotoninlB receptor binding potential in major depressive disorder[J]. Psychopharmacology (Berl), 2011,213 (2-3): 547-553.
  • 7Shelton R C, Sanders-Bush E, Manier D H, et al. Elevated 5-HT2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A[J]. Neuroscience, 2009, 158 (4): 1406-1415.
  • 8Sharon Rosenzweig-Lipson,Annmarie Sabb, Gary Stack, et al. Antidepressant-like effects of the novel, selective, 5-HT2c receptor agonist WAY-163909 in rodents[J]. Psychopharmacology, 2007, 192 (2): 159-170.
  • 9Li Bing-jin,Zhao Jing,Lv Jia-yin,et al. Additive antidepressant-like effects of fasting with imipramine via modulation of 5-HT2 receptors in the mice[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2014,48 (3): 199- 206.
  • 10Laurent P Lacroix, Lee A Dawson, Jim J Hagan, et al. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex[J]. Synapse,2004,51 (2): 158-164.

二级参考文献31

  • 1卢峻,时宇静,费宇彤,图娅.抑郁症与神经可塑性(综述)[J].中国心理卫生杂志,2006,20(1):43-46. 被引量:19
  • 2Murray CJL, Lopez AD. Global mortality, disability and the contribution of risk factors : global burden of disease study. Lancet, 1997, 349: 1436-1442.
  • 3Phillips MR, Zhang J, Shi Q, et al. Prevalence, treat- ment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet, 2009,373 : 2041-2053.
  • 4Jan M. Deussing:Animal models of depression. Drug Dis- eovery Today : Disease Models, 2006,3 : 4.
  • 5Zhao YN, Ma R, Shen J, et al. A mouse model of depres- sion induced by repeated corticosterone injections. Euro- pean J Pharmacol, 2008,581 : 113-120.
  • 6Zhou Y. Antidepressant-like effects of the fractions of Xi- aoyaosan on rat model of chronic unpredictable milds tress. J Ethnopharmacol, 2011,1016:9-17.
  • 7Gould TD, Dao DT, Kovacsics CE. The open field test. mood and anxiety related phenotypes in mice. Neurometh- ods, 2009,1 : 1-20.
  • 8Willner P. Validity, reliability and utility of the chronic mild stress model of depression : a lO-year review and e- valuation. Psychopharmacology, 1997,134 : 319-329.
  • 9Boyle MP, Brewer JA, Funatsu M, et al. Acquired deficit of forebrain glucocorticoid receptor produces depression- like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci USA, 2006, 102 (2) : 473-478.
  • 10张卫华,谭云龙,周沫,周东丰.精神分裂症患者脑源性神经营养因子水平及其与临床症状的关系[J].中华精神科杂志,2007,40(4):197-200. 被引量:15

共引文献19

同被引文献155

引证文献10

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部